PMV Pharmaceuticals Inc expected to post a loss of 39 cents a share - Earnings Preview

Pmv Pharmaceuticals

26/02/2024 15:30

* PMV Pharmaceuticals Inc  PMVP.OQ   PMVP.O  is expected
to show
no change in quarterly revenue when it reports  results on
February 28 (estimated) for the period ending December 31 2023
    * 
    * ​LSEG's mean analyst estimate for PMV Pharmaceuticals Inc
is for
a loss of 39 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for PMV
Pharmaceuticals Inc is $7.00​, above​ its last closing price
of $1.67. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.45       -0.45      -0.34     Beat    23.8
 Jun. 30 2023  -0.46       -0.47      -0.38     Beat    20
 Mar. 31 2023  -0.44       -0.46      -0.42     Beat    8.4​
 Dec. 31 2022  -0.44       -0.44      -0.43     Beat    1.9
 ​​Sep.        -0.43       -0.42      -0.40     Beat    5.5
 30 2022                                                
 Jun. 30 2022  -0.42       -0.41      -0.38     Beat    6.9​
 Mar. 31 2022  -0.43       -0.40      -0.41     Missed  -1.7
 Dec. 31 2021  -0.35       -0.35      -0.40     Missed  -15.4
 This summary was machine generated February 26 at 15:30 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)